We attempted to fractionate the alkaline phosphatase (ALP, EC 3.1.3.1) in human sera into liver and bone isoenzymes by "high-performance" liquid chromatography, using the Mono Q column (Pharmacia, Uppsala, Sweden) method described by Schoennu et al.
We attempted to fractionate the alkaline phosphatase (ALP, EC 3.1.3.1) in human sera into liver and bone isoenzymes by "high-performance" liquid chromatography, using the Mono Q column (Pharmacia, Uppsala, Sweden) method described by Schoennu et al.
(1). We hoped to develop an independent method for the resolution of isoenzymes, which could then be used to evaluate resolution of bone and liver ALP activities by monoclonal antibodies and wheat-germ lectin. However, as reported by Beilby and Chin (2), we were also unable to completely separate bone and liver ALP by this chromatographic method, even after prior enrichment of the bone or liver isoenzyme by wheat-germ lectin affinity chromatography.
For a source of human bone or liver
ALP isoenzymes,
we selected human sera with elevated ALP activity (>2000 UIL) and >90% liver or bone including fraction size, elution gradient, and column source and size, we conclude that human liver and bone ALP cannot be completely separated by this method. We thus confirm the report of Hsu and Chen (4), who also observed a heterogeneity of human liver ALP rather than two distinct peaks when using Mono Q for "high-performance" liquid chromatography of ALP isoenzymes.
